Radixact platform draws attention to pediatric radiotherapy progress at ESTRO26

Radixact platform draws attention to pediatric radiotherapy progress at ESTRO26
Accuray advances pediatric radiotherapy

Accuray hosted a presentation at ESTRO26 featuring Dr Liam Herbert from Queen Elizabeth Hospital Birmingham, UK, highlighting developments in pediatric radiotherapy using the Radixact platform.

Attendees were invited to view a video where Dr Herbert discusses the applications and benefits of Radixact and TomoTherapy in treating young patients, emphasizing innovation in cancer care for children.

Accuray previously unveiled its Radixact system for paediatric radiotherapy at the ESTRO Stage during the same conference, according to an earlier report here. In a separate study, data from 50 acoustic neuroma patients treated with the company's CyberKnife platform showed minimal toxicity and promising tumor control outcomes here. These developments reflect the company's continued focus on advancing precision radiotherapy technologies.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.